Discussion topic:
COVID vaccines – is there a need for boosters in view of the emergence of variants and waning immunity?
Session 3 : 17:00-19:00 - (english)

Chair: Professor Anna Durbin, Johns Hopkins Bloomberg School of Public Health, USA and Member of the ADVAC Scientific Committee

Dr Jakob Cramer, Coalition for Epidemic Preparedness Innovations (CEPI), London, UK
Booster versus 2+1 primary immunisation vaccination: Does it matter?

Professor Stanley Plotkin, University of Pennsylvania, USA
Correlates of Protection as Indicators for Third Doses of COVID Vaccines